Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced neutralizing antibody response to SARS‐CoV‐2 vaccine booster dose in people living with HIV with severe immunosuppression
Anaïs Corma‐Gómez, Marta Fernández‐Fuertes, Laura Viñuela, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Open Access | Times Cited: 10

Showing 10 citing articles:

Dynamic SARS-CoV-2-specific B-cell and T-cell responses induced in people living with HIV after a full course of inactivated SARS-CoV-2 vaccine
Xiuwen Wang, Xiaodong Yang, Xin Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Safety and immunogenicity of homologous prime‐boost CoronaVac vaccine in people living with HIV in China: A multicenter prospective cohort study
Yuxiao Wang, Xinquan Lan, Ying Qiao, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Closed Access | Times Cited: 2
Immunogenicity and effectiveness of COVID-19 booster vaccination among people living with HIV: a systematic review and meta-analysis
Meng-Qun Cheng, Rong Li, Zhiying Weng, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
SARS‐CoV‐2 vaccine immunogenicity for people living with HIV: A systematic review and meta‐analysis
Mads Herluf Søndergaard, Jannifer Jasmin Thavarajah, Henry C. Henson, et al.
HIV Medicine (2023) Vol. 25, Iss. 1, pp. 16-37
Open Access | Times Cited: 4
SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy
Ilaria Vicenti, Monica Basso, Nicole Pirola, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 871-871
Open Access | Times Cited: 2
Omicron BA.4/5 neutralization and cell‐mediated immune responses in relation to baseline immune status and breakthrough infection among PLWH: A follow‐up cohort study
Haoting Zhan, Yuchen Xie, Yongmei Liu, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Closed Access
A Multivariant Surrogate Virus Neutralization Test Demonstrates Distinct SARS-CoV-2-Specific Antibody Responses in People Living with HIV after a Fourth Monovalent mRNA Vaccination or an Omicron Breakthrough Infection
David Niklas Springer, Simon Daller, Michael Knappik, et al.
Diagnostics (2024) Vol. 14, Iss. 8, pp. 822-822
Open Access
Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study—ANRS0001s COV-POPART
Paul Loubet, Jean‐Daniel Lelièvre, Alexis François, et al.
International Journal of Infectious Diseases (2024) Vol. 146, pp. 107110-107110
Open Access
SARS-CoV-2 Humoral and Cellular Immune Responses in People Living with HIV
Simona Ruţă, Corneliu Petru Popescu, Lilia Matei, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 663-663
Open Access
Neutralizing Activity and T-Cell Responses Against Wild Type SARS-CoV-2 Virus and Omicron BA.5 Variant After Ancestral SARS-CoV-2 Vaccine Booster Dose in PLWH Receiving ART Based on CD4 T-Cell Count
Na‐Young Ha, Ah-Ra Kim, Hyeongseok Jeong, et al.
Journal of Korean Medical Science (2024) Vol. 40, Iss. 9
Open Access
Page 1

Scroll to top